iofetamine has been researched along with Arterial Occlusive Diseases in 14 studies
Iofetamine: An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
Excerpt | Relevance | Reference |
---|---|---|
" The purpose of the present exploratory study was to determine whether blood pressure-lowering therapy with the combination of the angiotensin receptor blocker losartan plus hydrochlorothiazide (LPH) worsens brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease." | 7.78 | Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusiv ( Kobayashi, M; Kuroda, H; Ogasawara, K; Ogawa, A; Saura, H; Suzuki, T; Terasaki, K; Yamashita, T, 2012) |
" The purpose of the present exploratory study was to determine whether blood pressure-lowering therapy with the combination of the angiotensin receptor blocker losartan plus hydrochlorothiazide (LPH) worsens brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease." | 3.78 | Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusiv ( Kobayashi, M; Kuroda, H; Ogasawara, K; Ogawa, A; Saura, H; Suzuki, T; Terasaki, K; Yamashita, T, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (35.71) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chida, K | 2 |
Ogasawara, K | 4 |
Kuroda, H | 3 |
Aso, K | 2 |
Kobayashi, M | 4 |
Fujiwara, S | 2 |
Yoshida, K | 2 |
Terasaki, K | 4 |
Ogawa, A | 4 |
Suzuki, T | 2 |
Kubo, Y | 1 |
Saura, H | 1 |
Yamashita, T | 1 |
Inoue, T | 1 |
Fujimura, M | 1 |
Shimizu, H | 1 |
Takahashi, Y | 1 |
Tominaga, T | 1 |
Ito, H | 1 |
Sasoh, M | 1 |
Okuguchi, T | 1 |
Yukawa, H | 1 |
Kimura, Y | 1 |
Oku, N | 1 |
Kajimoto, K | 1 |
Katoh, H | 1 |
Tanaka, MR | 1 |
Takasawa, M | 1 |
Imaizumi, M | 1 |
Kitagawa, K | 1 |
Hori, M | 1 |
Hatazawa, J | 1 |
Hirano, T | 1 |
Minematsu, K | 1 |
Hasegawa, Y | 1 |
Tanaka, Y | 1 |
Hayashida, K | 1 |
Yamaguchi, T | 1 |
Ueno, M | 1 |
Nishizawa, S | 1 |
Toyoda, H | 1 |
Shimono, T | 1 |
Miyamoto, S | 1 |
Hashimoto, N | 1 |
Konishi, J | 1 |
Morita, K | 1 |
Ono, S | 1 |
Fukunaga, M | 1 |
Otsuka, N | 1 |
Nagai, K | 1 |
Furukawa, T | 1 |
Muranaka, A | 1 |
Mimura, H | 1 |
Yanagimoto, S | 1 |
Tomomitsu, T | 1 |
Cesaro, P | 1 |
Moretti, JL | 1 |
Caron, JP | 1 |
Roualdes, B | 1 |
Louarn, F | 1 |
N'guyen, JP | 1 |
Gaston, A | 1 |
Degos, JD | 1 |
Honda, N | 1 |
Machida, K | 1 |
Takishima, T | 1 |
Kaizu, H | 1 |
Sugimoto, E | 1 |
Higa, T | 1 |
Tanaka, T | 1 |
Ikekubo, K | 1 |
Komatsu, T | 1 |
Torizuka, K | 1 |
Holman, BL | 1 |
Jolesz, FA | 1 |
Polak, JF | 1 |
Kronauge, JF | 1 |
Adams, DF | 1 |
Etani, H | 1 |
Kimura, K | 1 |
Yoneda, S | 1 |
Tsuda, Y | 1 |
Nakamura, M | 1 |
Isaka, Y | 1 |
Uehara, A | 1 |
Nakamura, Y | 1 |
Ohmori, H | 1 |
Takahashi, H | 1 |
1 trial available for iofetamine and Arterial Occlusive Diseases
Article | Year |
---|---|
Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Autoradiography; Cerebral Arteries; Cerebro | 2003 |
13 other studies available for iofetamine and Arterial Occlusive Diseases
Article | Year |
---|---|
Central benzodiazepine receptor binding potential and CBF images on SPECT correlate with oxygen extraction fraction images on PET in the cerebral cortex with unilateral major cerebral artery occlusive disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Basal Ganglia; Carotid Stenosis; Cerebellum; Cerebral Cort | 2011 |
Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamid
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Area Under Curve; Arterial Occlusive Diseases; Carbon | 2012 |
Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusiv
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arterial Occlusive Di | 2012 |
Quantitative assessment of cerebral hemodynamics using single photon emission computed tomography with venous blood sampling.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Brain; Cerebrovascular Circulation; Cerebro | 2013 |
Diastolic blood pressure influences cerebrovascular reactivity measured by means of 123I-iodoamphetamine brain single photon emission computed tomography in medically treated patients with occlusive carotid or middle cerebral artery disease.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Blood Pressure; Brain; Carotid Artery Diseases; Ce | 2006 |
Acetazolamide reactivity on 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Amphetamines; Arterial Occlusive Diseases; Cerebral A | 1994 |
Assessment of cerebral hemodynamics before and after revascularization in patients with occlusive cerebrovascular disease by means of quantitative IMP-SPECT with double-injection protocol.
Topics: Aged; Arterial Occlusive Diseases; Carotid Stenosis; Cerebral Arteries; Cerebral Revascularization; | 2001 |
[The usefulness of single photon emission computed tomography using N-isopropyl-p-[123I]-iodoamphetamine and 99mTc-hexamethylpropyleneamine oxime in patients with moyamoya disease].
Topics: Adolescent; Adult; Amphetamines; Arterial Occlusive Diseases; Brain; Cerebrovascular Circulation; Ch | 1990 |
[Cerebral tomoscintigraphy with N-isopropyl-p-I123-iodoamphetamine. Value in cerebral ischemic pathology].
Topics: Amphetamines; Arterial Occlusive Diseases; Brain Ischemia; Cerebellar Diseases; Cerebral Arterial Di | 1985 |
Iodine-123 IMP SPECT before and after bypass surgery in a patient with occlusion of left anterior and middle cerebral arteries with basal abnormal telangiectasis (unilateral Moyamoya disease).
Topics: Adult; Amphetamines; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Cerebral Revasculariza | 1987 |
SPECT with N-isopropyl-p iodoamphetamine in occlusive cerebrovascular diseases.
Topics: Amphetamines; Arterial Occlusive Diseases; Cerebrovascular Disorders; Humans; Iodine Radioisotopes; | 1986 |
Comparison of I-123 IMP cerebral uptake and MR spectroscopy following experimental carotid occlusion.
Topics: Amphetamines; Animals; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebral Infarction; Ge | 1985 |
[Cerebral perfusion imaging with N-isopropyl-(123I) P-iodoamphetamine (123I-IMP): its planar imaging and semiquantitative analysis in cases with internal carotid occlusion].
Topics: Adult; Aged; Amphetamines; Arterial Occlusive Diseases; Brain; Carotid Artery Diseases; Carotid Arte | 1985 |